✦ LIBER ✦

928 Insulin-like growth factor-I (IGF-I) therapy in patients with advanced liver cirrhosis. Results of a randomized double-blind, controlled pilot study

✍ Scribed by Mariam Conchillo; Robert de Knegt; Marina Payeras; Jorge Quiroga; Brano Sangro; Ignacio Herrero; Carl Yoshizawa; Peter Jansen; Bruce Scharschmidt; Jesus Prieto

Book ID: 119530830
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 140 KB
Volume: 38
Category: Article
ISSN: 0270-9139
DOI: 10.1016/s0270-9139(03)80966-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

180 Results of a randomized double-blind

180 Results of a randomized double-blind, controlled pilot study of the administration of insulin-like growth factor-I (IGF-I) in patients with liver cirrhosis

✍ M. Conchillo; R. de Knegt; M. Payeras; J. Quiroga; B. Sangro; J.I. Herrero; I. C 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Insulin-like growth factor I (IGF-I) rep

Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: Results of a pilot randomized controlled clinical trial

✍ Mariam Conchillo; Robert J. de Knegt; Marina Payeras; Jorge Quiroga; Bruno Sangr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Rapid and sustained reduction of serum g

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel®therapy: a randomized, placebo-controlled, multicenter study with a 52

✍ Shlomo Melmed; David Cook; Jochen Schopohl; Miklos I. Goth; Karen S. L. Lam; Jos 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 395 KB

648 POSTER A phase I dose-escalation stu

648 POSTER A phase I dose-escalation study of weekly IMC-A12, a fully human insulin like growth factor-I receptor (IGF-IR) IgG1 monoclonal antibody (Mab), in patients (pts) with advanced cancer

✍ C. Higano; M. Gordon; P. LoRusso; F. Fox; T. Katz; J. Roecker; E. Rowinsky; H. Y 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Phase 1 study of ganitumab (AMG 479), a

Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors

✍ Haruyasu Murakami, Toshihiko Doi, Nobuyuki Yamamoto… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 228 KB

554 POSTER Pharmacokinetic (PK) and phar

554 POSTER Pharmacokinetic (PK) and pharmacodynamic (PD) results of Phase I studies of IMC-A12, a fully human insulin like growth factor-I receptor IgG1 monoclonal antibody, in patients with advanced solid malignancies

✍ M.L. Rothenberg; E. Poplin; P. LoRusso; E. Yu; J. Schwartz; F. Fox; J. Mehnert; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB